Oncogenic human T-cell lymphotropic virus type 1 tax suppression of primary innate immune signaling pathways

Journal of Virology

Volumn 89, Issue 9, 2015, Pages 4880-4893

  Hyun, Jinhee ^a   Ramos, Juan Carlos ^b   Toomey, Ngoc ^b   Balachandran, Siddharth ^c   Lavorgna, Alfonso ^d   Harhaj, Edward ^d   Barber, Glen N ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; HELICASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; MDA5 PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; TAX PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG; VIRUS RNA; TAX PROTEIN, HUMAN T-LYMPHOTROPHIC VIRUS 1;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; ENZYME INHIBITION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOMODULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; VESICULOVIRUS; VIRUS CARCINOGENESIS; VIRUS LATENCY; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; HOST PATHOGEN INTERACTION; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNE EVASION; IMMUNOLOGICAL TOLERANCE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

ANIMALS; CELL LINE; GENE PRODUCTS, TAX; HOST-PATHOGEN INTERACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; IMMUNITY, INNATE; MICE, INBRED BALB C; SIGNAL TRANSDUCTION;

EID: 84928535607     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02493-14     Document Type: Article

References (58)

1. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol 20:197-216. http://dx.doi.org/10.1146/annurev.immunol.20.083001.084359.
2. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373-384. http://dx.doi.org/10.1038/ni.1863.
3. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738. http://dx.doi.org/10.1038/35099560.
4. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S. 2002. Cutting edge: a novel Toll/IL-1 receptor domaincontaining adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 169:6668-6672. http://dx.doi.org/10.4049/jimmunol.169.12.6668.
5. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4:161-167. http://dx.doi.org/10.1038/ni886.
6. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643. http://dx.doi.org/10.1126/science.1087262.
7. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 101:5598-5603. http://dx.doi.org/10.1073/pnas.0400937101.
8. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529. http://dx.doi.org/10.1126/science.1093620.
9. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of singlestranded RNA. Science 303:1529-1531. http://dx.doi.org/10.1126/science.1093616.
10. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737. http://dx.doi.org/10.1038/ni1087.
11. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFNinducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101:17264-17269. http://dx.doi.org/10.1073/pnas.0407639101.
12. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
13. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 6:981-988. http://dx.doi.org/10.1038/ni1243.
14. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682. http://dx.doi.org/10.1016/j.cell.2005.08.012.
15. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727-740. http://dx.doi.org/10.1016/j.molcel.2005.08.014.
16. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172. http://dx.doi.org/10.1038/nature04193.
17. Balachandran S, Thomas E, Barber GN. 2004. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432:401-405. http://dx.doi.org/10.1038/nature03124.
18. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G. 2006. Critical role of TRAF3 in the Toll-like receptordependent and-independent antiviral response. Nature 439:208-211. http://dx.doi.org/10.1038/nature04374.
19. Zhao T, Yang L, Sun Q, Arguello M, Ballard DW, Hiscott J, Lin R. 2007. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol 8:592-600. http://dx.doi.org/10.1038/ni1465.
20. Watanabe T, Seiki M, Yoshida M. 1983. Retrovirus terminology. Science 222:1178.
21. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415-7419. http://dx.doi.org/10.1073/pnas.77.12.7415.
22. Yoshida M, Miyoshi I, Hinuma Y. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79:2031-2035. http://dx.doi.org/10.1073/pnas.79.6.2031.
23. Nakayama D, Katamine S, Kanazawa H, Shibuya N, Kawase K, Moriuchi R, Miyamoto T, Hino S. 1990. Amplification of HTLV-1-related sequences among patients with neurological disorders in highly endemic Nagasaki: lack of evidence for association of HTLV-1 with multiple sclerosis. Jpn J Cancer Res 81:238-246. http://dx.doi.org/10.1111/j.1349-7006.1990.tb02556.x.
24. Arisawa K, Soda M, Endo S, Kurokawa K, Katamine S, Shimokawa I, Koba T, Takahashi T, Saito H, Doi H, Shirahama S. 2000. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 85:319-324. http://dx.doi.org/10.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B.
25. Akagi T, Ono H, Shimotohno K. 1995. Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1. Blood 86:4243-4249.
26. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M. 1990. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 87:1071-1075. http://dx.doi.org/10.1073/pnas.87.3.1071.
27. Ruben S, Poteat H, Tan TH, Kawakami K, Roeder R, Haseltine W, Rosen CA. 1988. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science 241:89-92. http://dx.doi.org/10.1126/science.2838905.
28. Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. 1988. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science 241:1652-1655. http://dx.doi.org/10.1126/science.2843985.
29. Smith MR, Greene WC. 1990. Identification of HTLV-I tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4:1875-1885. http://dx.doi.org/10.1101/gad.4.11.1875.
30. Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L. 2008. The HTLV-1 Tax interactome. Retrovirology 5:76. http://dx.doi.org/10.1186/1742-4690-5-76.
31. Harhaj EW, Harhaj NS. 2005. Mechanisms of persistent NF-kappaB activation by HTLV-I tax. IUBMB Life 57:83-91. http://dx.doi.org/10.1080/15216540500078715.
32. Grassmann R, Aboud M, Jeang KT. 2005. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24:5976-5985. http://dx.doi.org/10.1038/sj.onc.1208978.
33. Suzuki T, Kitao S, Matsushime H, Yoshida M. 1996. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J 15:1607-1614.
34. Neuveut C, Low KG, Maldarelli F, Schmitt I, Majone F, Grassmann R, Jeang KT. 1998. Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol 18:3620-3632.
35. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678. http://dx.doi.org/10.1038/nature07317.
36. Ishikawa H, Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788-792. http://dx.doi.org/10.1038/nature08476.
37. Merrick WC, Kemper WM, Anderson WF. 1975. Purification and characterization of homogeneous initiation factor M2A from rabbit reticulocytes. J Biol Chem 250:5556-5562.
38. Komuro A, Bamming D, Horvath CM. 2008. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 43:350-358. http://dx.doi.org/10.1016/j.cyto.2008.07.011.
39. Belkowski LS, Sen GC. 1987. Inhibition of vesicular stomatitis viral mRNA synthesis by interferons. J Virol 61:653-660.
40. Fontoura BM, Faria PA, Nussenzveig DR. 2005. Viral interactions with the nuclear transport machinery: discovering and disrupting pathways. IUBMB Life 57:65-72. http://dx.doi.org/10.1080/15216540500078608.
41. Panne D. 2008. The enhanceosome. Curr Opin Struct Biol 18:236-242. http://dx.doi.org/10.1016/j.sbi.2007.12.002.
42. Balachandran S, Venkataraman T, Fisher PB, Barber GN. 2007. Fasassociated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol 178:2429-2439. http://dx.doi.org/10.4049/jimmunol.178.4.2429.
43. Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, Konig M, Kalinke U, Pasparakis M, Tschopp J. 2008. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28:651-661. http://dx.doi.org/10.1016/j.immuni.2008.03.013.
44. Rajput A, Kovalenko A, Bogdanov K, Yang SH, Kang TB, Kim JC, Du J, Wallach D. 2011. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 34:340-351. http://dx.doi.org/10.1016/j.immuni.2010.12.018.
45. Feng S, Yang Y, Mei Y, Ma L, Zhu DE, Hoti N, Castanares M, Wu M. 2007. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 19:2056-2067. http://dx.doi.org/10.1016/j.cellsig.2007.05.016.
46. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, Tschopp J. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5:503-507. http://dx.doi.org/10.1038/ni1061.
47. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T. 2010. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 3:re4. http://dx.doi.org/10.1126/scisignal.3115re4.
48. Cusson-Hermance N, Khurana S, Lee TH, Fitzgerald KA, Kelliher MA. 2005. Rip1 mediates the Trif-dependent toll-like receptor 3-and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 280:36560-36566. http://dx.doi.org/10.1074/jbc. M506831200.
49. Hoebe K, Janssen EM, Kim SO, Alexopoulou L, Flavell RA, Han J, Beutler B. 2003. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 4:1223-1229. http://dx.doi.org/10.1038/ni1010.
50. Huye LE, Ning S, Kelliher M, Pagano JS. 2007. Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. Mol Cell Biol 27:2910-2918. http://dx.doi.org/10.1128/MCB.02256-06.
51. Matsuoka M. 2003. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22:5131-5140. http://dx.doi.org/10.1038/sj.onc.1206551.
52. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777. http://dx.doi.org/10.1038/nature03464.
53. Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M, Bangham CR. 2003. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299:1713-1716. http://dx.doi.org/10.1126/science.1080115.
54. Matsuoka M, Jeang KT. 2007. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7:270-280. http://dx.doi.org/10.1038/nrc2111.
55. Takeda K, Akira S. 2004. TLR signaling pathways. Semin Immunol 16: 3-9. http://dx.doi.org/10.1016/j.smim.2003.10.003.
56. Zhang J, Yamada O, Kawagishi K, Araki H, Yamaoka S, Hattori T, Shimotohno K. 2008. Human T-cell leukemia virus type 1 Tax modulates interferon-alpha signal transduction through competitive usage of the coactivator CBP/p300. Virology 379:306-313. http://dx.doi.org/10.1016/j.virol.2008.06.035.
57. DiPerna G, Stack J, Bowie AG, Boyd A, Kotwal G, Zhang Z, Arvikar S, Latz E, Fitzgerald KA, Marshall WL. 2004. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem 279:36570-36578. http://dx.doi.org/10.1074/jbc. M400567200.
58. Unterstab G, Ludwig S, Anton A, Planz O, Dauber B, Krappmann D, Heins G, Ehrhardt C, Wolff T. 2005. Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci USA 102:13640-13645. http://dx.doi.org/10.1073/pnas.0502883102.